Skip to main content
. 2019 Feb 20;9(5):1426–1452. doi: 10.7150/thno.31683

Figure 10.

Figure 10

Preparation process of LbL-LCN/SF and safety comparison of different treatments 153. (A) Schematic representation of fabrication process of LbL-LCN/SF. (B) Effects of free SF, LCN, LCN/SF, and LbL-LCN/SF on hemolytic toxicity. In vitro cytotoxicity of control (blank LbL-LCN), free SF, and LbL-LCN/SF on HepG2 cell lines following 24 h (C) and 72 h incubation (D). Copyright 2015. Reproduced with permission from the American Chemical Society.